|
|
|
Volumn 16, Issue 10 Suppl 11, 2002, Pages 23-29
|
|
Darbepoetin alfa administered every 2 weeks alleviates anemia in cancer patients receiving chemotherapy.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
DRUG DERIVATIVE;
ERYTHROPOIETIN;
NOVEL ERYTHROPOIESIS STIMULATING PROTEIN;
RECOMBINANT ERYTHROPOIETIN;
ANEMIA;
ARTICLE;
BLOOD;
BREAST TUMOR;
CHEMICALLY INDUCED DISORDER;
CLINICAL TRIAL;
COMPARATIVE STUDY;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG ADMINISTRATION;
FEMALE;
FEMALE GENITAL TRACT TUMOR;
GASTROINTESTINAL TUMOR;
HUMAN;
LUNG TUMOR;
MALE;
MALE GENITAL TRACT TUMOR;
MIDDLE AGED;
MULTICENTER STUDY;
NEOPLASM;
RANDOMIZED CONTROLLED TRIAL;
TREATMENT OUTCOME;
ANEMIA;
BREAST NEOPLASMS;
DRUG ADMINISTRATION SCHEDULE;
EPOETIN ALFA;
ERYTHROPOIETIN;
FEMALE;
GASTROINTESTINAL NEOPLASMS;
GENITAL NEOPLASMS, FEMALE;
GENITAL NEOPLASMS, MALE;
HUMANS;
LUNG NEOPLASMS;
MALE;
MIDDLE AGED;
NEOPLASMS;
TREATMENT OUTCOME;
|
|
EID: 0036781893
PISSN: 08909091
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (49)
|
|
References (0)
|
